PRODUCTION AND CHARACTERIZATION OF A MURINE HUMAN CHIMERIC ANTIIDIOTYPE ANTIBODY THAT MIMICS GANGLIOSIDE

被引:0
|
作者
HASTINGS, A
MORRISON, SL
KANDA, S
SAXTON, RF
IRIE, RF
机构
[1] UNIV CALIF LOS ANGELES, SCH MED, DEPT SURG ONCOL, LOS ANGELES, CA 90024 USA
[2] UNIV CALIF LOS ANGELES, JONSSON COMPREHENS CANC CTR, INST MOLEC BIOL, LOS ANGELES, CA 90024 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The V(L) and V(H) from a murine anti-idiotypic antibody that mimics ganglioside have been cloned, sequenced, and expressed as a chimeric mouse/human IgG1 antibody. The chimeric antibody retained a binding specificity indistinguishable from the original murine antibody. The V(H) was a member of V gam 3.8 family. The sequences are discussed in terms of ways in which proteins may mimic ganglioside epitopes.
引用
收藏
页码:1681 / 1686
页数:6
相关论文
共 50 条
  • [1] PRODUCTION AND CHARACTERIZATION OF A MOUSE HUMAN CHIMERIC ANTIBODY DIRECTED AGAINST HUMAN NEUROBLASTOMA
    AMSTUTZ, H
    RYTZ, C
    NOVAKHOFER, I
    SPYCHER, M
    SCHUBIGER, PA
    BLASER, K
    MORGENTHALER, JJ
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1993, 53 (01) : 147 - 152
  • [2] INITIAL EXPERIENCE IN TREATING HUMAN LYMPHOMA WITH A CHIMERIC UNIVALENT DERIVATIVE OF MONOCLONAL ANTIIDIOTYPE ANTIBODY
    HAMBLIN, TJ
    CATTAN, AR
    GLENNIE, MJ
    MACKENZIE, MR
    STEVENSON, FK
    WATTS, HF
    STEVENSON, GT
    [J]. BLOOD, 1987, 69 (03) : 790 - 797
  • [3] MURINE MONOCLONAL ANTIIDIOTYPE ANTIBODY AS A POTENTIAL NETWORK ANTIGEN FOR HUMAN CARCINOEMBRYONIC ANTIGEN
    BHATTACHARYACHATTERJEE, M
    MUKERJEE, S
    BIDDLE, W
    FOON, KA
    KOHLER, H
    [J]. JOURNAL OF IMMUNOLOGY, 1990, 145 (08): : 2758 - 2765
  • [4] CHARACTERIZATION OF A TUMOR SPECIFIC GENETICALLY ENGINEERED MURINE HUMAN CHIMERIC MONOCLONAL-ANTIBODY
    BROWN, B
    DAVIS, G
    SALTZGABERMULLER, J
    SIMON, P
    SHAW, P
    SANDS, H
    MOORE, G
    [J]. FEDERATION PROCEEDINGS, 1987, 46 (04) : 1342 - 1342
  • [5] MONOCLONAL ANTIIDIOTYPE ANTIBODY TO HSV-1 NEUTRALIZING MONOCLONAL-ANTIBODY - PRODUCTION AND CHARACTERIZATION
    DAR, VS
    SETH, P
    [J]. DISEASE MARKERS, 1993, 11 (2-3) : 113 - 123
  • [6] PURIFICATION AND CHARACTERIZATION OF A TUMOR SPECIFIC GENETICALLY ENGINEERED MURINE HUMAN CHIMERIC MONOCLONAL-ANTIBODY
    BROWN, BA
    DAVIS, G
    SALTZGABERMULLER, J
    SIMON, P
    SHAW, PS
    MOORE, GP
    [J]. BRITISH JOURNAL OF CANCER, 1986, 54 (03) : 530 - 531
  • [7] MOLECULAR CHARACTERIZATION OF ANTIIDIOTYPE ANTIBODY-RESISTANT VARIANTS OF A MURINE B-CELL LYMPHOMA
    ROTH, MS
    WEINER, GJ
    ALLEN, EA
    TERRY, VH
    HARNDEN, CE
    BOEHNKE, M
    KAMINSKI, MS
    GINSBURG, D
    [J]. JOURNAL OF IMMUNOLOGY, 1990, 145 (02): : 768 - 777
  • [8] DEVELOPMENT AND FUNCTIONAL-CHARACTERIZATION OF A MURINE HUMAN CHIMERIC ANTIBODY WITH SPECIFICITY FOR THE HUMAN INTERLEUKIN-2 RECEPTOR
    VANDEVYVER, C
    STEUKERS, M
    LAMBRECHTS, J
    HEYLIGEN, H
    RAUS, J
    [J]. MOLECULAR IMMUNOLOGY, 1993, 30 (10) : 865 - 876
  • [9] CONSTRUCTION AND EXPRESSION OF A TUMOR SPECIFIC MURINE HUMAN CHIMERIC ANTIBODY
    MOORE, GP
    [J]. BRITISH JOURNAL OF CANCER, 1987, 56 (04) : 512 - 512
  • [10] MURINE MONOCLONAL ANTIIDIOTYPE ANTIBODY (ALPHA) AS A PROBE TO DETECT HUMAN MONOCLONAL-ANTIBODY BOUND TO HUMAN TUMOR-TISSUES
    SAITO, H
    WEN, DR
    YAMAMOTO, S
    YAMAMOTO, T
    SAXTON, RE
    COCHRAN, AJ
    IRIE, RF
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 134 (01) : 121 - 128